Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test.
Authors/Creators
- Damiano Magrì1
- Massimo Piepoli2
- Giulia Gallo1
- Andrea Maruotti1
- Carlo Vignati3
- Elisabetta Salvioni3
- Massimo Mapelli3
- Stefania Paolillo4
- Pasquale Perrone Filardi4
- Davide Girola
- Marco Metra
- Angela B. Scardovi
- Rocco Lagioia
- Giuseppe Limongelli
- Michele Senni
- Domenico Scrutinio
- Michele Emdin
- Claudio Passino
- Carlo Lombardi
- Gaia Cattadori
- Gianfranco Parati
- Mariantonietta Cicoira
- Michele Correale
- Maria Frigerio
- Francesco Clemenza
- Maurizio Bussotti
- Marco Guazzi
- Roberto Badagliacca
- Susanna Sciomer
- Andrea Di Lenarda
- Aldo Maggioni
- Gianfranco Sinagra
- Massimo Volpe
- Piergiuseppe Agostoni
- 1. Ospedale S. Andrea Roma
- 2. Ospedale G. da Saliceto Piacenza
- 3. Centro Cardiologico Monzino
- 4. Federico II University of Naples, Italy
Description
Raw data of the paper:
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test.
Background
Heart failure with midrange ejection fraction (HFmrEF) represents a heterogeneous category where phenotype, as well as prognostic assessment, remains debated. The present study explores a specific HFmrEF subset, namely those who recovered from a reduced EF (rec-HFmrEF) and, particularly, it focuses on the possible additive prognostic role of cardiopulmonary exercise testing.
Methods and Results
We analyzed data from 4535 patients with HFrEF and 1176 patients with rec-HFmrEF from the Metabolic Exercise combined with Cardiac and Kidney Indexes database. The end point was cardiovascular death at 5 years. The median follow-up was 1343 days (25th–75th range 627–2403 days). Cardiovascular death occurred in 552 HFrEF and 61 rec-HFmrEF patients. The multivariate analysis confirmed an independent role of the MECKI score's variables in HFrEF (C-index = 0.744) whereas, in the rec-HFmrEF group, only age and peak oxygen uptake (pVO2) remained associated to the end point (C-index = 0.745). A peak oxygen uptake of ≤55% of predicted and a ventilatory efficiency of ≥31 resulted as the most accurate cut-off values in the outcome prediction.
Conclusions:
Present data support the cardiopulmonary exercise test and, particularly, the peak oxygen uptake, as a useful tool in the rec-HFmrEF prognostic assessment. A peak VO2 of ≤55% predicted and ventilatory efficiency of ≥31 might help to identify a high-risk rec-HFmrEF subgroup.